Posted in | Nanomedicine

Arrowhead Research CEO sa usapan Tumuon Company sa Nanomedicine

Arrowhead Research Corporation (NASDAQ: ARWR) ngayon inihayag na Dr Christopher Anzalone, Chief Executive Officer, ay nagtatanghal ng Rodman & Renshaw Taunang Global Investment Conference sa 5:45 pm EDT sa Martes, Setyembre 14, 2010, sa Hotel Palace sa New York, NY.

Dr Anzalone ay tatalakayin ng Kumpanya at ang nadagdagan focus sa nanomedicine portfolio nito, kabilang ang mga clinical resulta.

Source: http://www.arrowheadresearch.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit